'%2F%3E%3Cpath%20d%3D'M11%205H21M13.5%205V11.6A8.5%208.5%200%201%200%2018.5%2011.6V5'%20fill%3D'none'%20stroke%3D'%23fff'%20stroke-width%3D'3.4'%20stroke-linecap%3D'round'%20stroke-linejoin%3D'round'%2F%3E%3Cpath%20d%3D'M10.6%2019.6L13.9%2021.8L17.6%2018.4L21.4%2020.4'%20fill%3D'none'%20stroke%3D'%23fff'%20stroke-width%3D'2.6'%20stroke-linecap%3D'round'%20stroke-linejoin%3D'round'%2F%3E%3Ccircle%20cx%3D'17.6'%20cy%3D'18.4'%20r%3D'2.6'%20fill%3D'%23fff'%2F%3E%3C%2Fsvg%3E){kind=small}
Curis Lifesciences Limited
CURIS (NSE) · CURIS (BSE 215295) · ISIN INE1BZN01016 · Pharmaceuticals · listed 2025
Open the full company file Every section, filings and your notes, in the app.
Quarterly results
No quarterly results stored for this company yet.
Balance sheet
| As of | Total equity | Borrowings | Total assets |
|---|---|---|---|
| 31 Mar 2026 standalone | ₹47.36 cr | ₹21.59 cr | ₹81.52 cr |
| 30 Sep 2025 standalone | ₹20.43 cr | ₹14.81 cr | ₹49.39 cr |
Shareholding
| Promoter | FII | DII | Public |
|---|---|---|---|
| 68.03% | 1.05% | 4.63% | 31.97% |
Latest filings
- Annual Report FY2025-26 (New) 1 October 2026 · NSE
- Curis Lifesciences Limited has informed the Exchange regarding Outcome of Board Meeting held on September 07, 2026. 7 September 2026 · NSE
- Curis Lifesciences Limited has informed the Exchange regarding a press release dated Jun 23, 2026, titled "Press Release pertaining to audited financial results for the half year and yearended 31st Ma 23 June 2026 · NSE
- Curis Lifesciences Limited has informed the Exchange regarding Outcome of Board Meeting held on May 30, 2026 regarding considering and approving the Audited Standalone Financial Results of the company 30 May 2026 · NSE
- Outcome of Board Meeting held on May 30, 2026 to consider and approve the Audited Standalone Financial Results of the company for the half year and year ended on March 31, 2026. 30 May 2026 · NSE
Other companies in Pharmaceuticals
- Lupin Limited
- Sun Pharmaceutical Industries Limited
- Torrent Pharmaceuticals Limited
- Zydus Lifesciences Limited
- Ajanta Pharma Limited
- Alivus Life Sciences Limited
- Wockhardt Limited
- Morepen Laboratories Limited
Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 1 October 2026.
Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.